Coming back to CAYSTON
Learn about Chelsea and Robin’s experiences and get tips for staying on track with CAYSTON
CAYSTON is a prescription antibacterial medicine used to improve breathing symptoms in people with cystic fibrosis (CF) who have a lung infection due to Read More
Coming back to CAYSTON
Learn about Chelsea and Robin’s experiences and get tips for staying on track with CAYSTON
You are now leaving the CAYSTON website. CAYSTON.com offers links to external pages and is not responsible for any content published on the third-party website you are about to enter. Gilead has not reviewed and does not endorse any information presented on third-party websites.
CAYSTON is a prescription antibacterial medicine used to improve breathing symptoms in people with cystic fibrosis (CF) who have a lung infection due to Pseudomonas aeruginosa (Pa). CAYSTON is not for infections caused by other bacteria or viruses, such as the common cold. It is not known if CAYSTON is safe and effective in children under the age of 7 or in people with FEV1 <25% or >75% predicted.
Do not take CAYSTON if you are allergic to aztreonam, or any of the ingredients in CAYSTON.
CAYSTON may cause serious side effects, including:
The most common side effects of CAYSTON include cough, nasal congestion, wheezing, sore throat, fever, chest discomfort, stomach area pain, and vomiting.
These are not all the possible side effects of CAYSTON. Tell your healthcare provider if you have any new or worsening symptoms while taking CAYSTON and about any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
CAYSTON is a prescription antibacterial medicine used to improve breathing symptoms in people with cystic fibrosis (CF) who have a lung infection due to Pseudomonas aeruginosa (Pa). CAYSTON is not for infections caused by other bacteria or viruses, such as the common cold. It is not known if CAYSTON is safe and effective in children under the age of 7 or in people with FEV1 <25% or >75% predicted.
Please see full Prescribing Information, including Patient Information and Patient Instructions for Use.